Nevertheless, we investigated both the role of SRSF1 as a potential poor prognostic factor in GBM patients and its oncogenic function through correlations with other predictors of glioma malignant behavior, including cell migration, blood vascular microvessel density (MVD) and autophagy. Here, SRSF1 is linked to glioblastoma.